HIGHLIGHTS
- who: Raisa A. Glabman et al. from the National Institutes of Health, Bethesda, MD, USA Michigan State University, East Lansing, MI, USA have published the paper: Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy, in the Journal: Cancers 2022, 14, 3906. of 10/08/2022
- what: In this review, the authors focus on CAFs, discuss their biologic tumor-promoting functions and recent advancements in the development of CAF-targeting cancer therapies.
SUMMARY
Over 1.9 million new cancer cases are expected in the United_States in 2022, and solid tumors comprise . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.